NeuroMetrix, Inc. (NURO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Shai N. Gozani M.D., Ph.D. | Founder, Chairman, CEO, President & Secretary | 359.98k | -- | 1965 |
| Mr. Thomas T. Higgins | Senior VP, CFO & Treasurer | 359.12k | -- | 1952 |
| Ms. Susan M. Bell R.N. | Senior Vice President of Population Health & Value Based Care | -- | -- | -- |
NeuroMetrix, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 13
Description
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Corporate Governance
Upcoming Events
March 31, 2025 at 10:59 AM UTC
NeuroMetrix, Inc. Earnings Date
Recent Events
May 2, 2025 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
May 31, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)